Next Article in Journal
Research Advances in Cancer-Associated Fibroblasts in Prostate Cancer Progression
Previous Article in Journal
Association of Plasma Placental Growth Factor with White Matter Hyperintensities in Alzheimer’s Disease
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

A Safety Evaluation of N-Acetylglucosamine Produced by Bacillus subtilis BNZR 2-7: A Comprehensive In Vitro and In Vivo Genotoxicity Assessment

1
School of Food Science, Shanxi Normal University, Taiyuan 030031, China
2
College of Life Science, Shanxi Normal University, Taiyuan 030031, China
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work and should be considered co-first authors.
Biomolecules 2025, 15(10), 1368; https://doi.org/10.3390/biom15101368
Submission received: 23 August 2025 / Revised: 21 September 2025 / Accepted: 23 September 2025 / Published: 26 September 2025
(This article belongs to the Section Bio-Engineered Materials)

Abstract

N-acetylglucosamine (GlcNAc) is an important functional monosaccharide that serves as a key component in macromolecules such as cell walls and chitin. It has a wide range of applications in medicine, health supplements, and the chemical industry, leading to a growing market demand. This study evaluated the potential genotoxicity of GlcNAc produced by Bacillus subtilis BNZR 2-7 through a comprehensive assessment in vitro and in vivo assays. GlcNAc was non-mutagenic in the Ames test using Salmonella typhimurium and Escherichia coli. Meanwhile, GlcNAc was non-genotoxic in the in vitro micronucleus assay using Chinese hamster ovary cells. In the in vivo assays, GlcNAc was non-genotoxic in the in vivo mammalian erythrocyte micronucleus test and spermatocyte chromosome aberration test in mice. These studies provide additional evidence that GlcNAc produced by Bacillus subtilis BNZR 2-7 is not genotoxic at the doses tested, supporting its safety for use in foods.
Keywords: N-acetylglucosamine; Bacillus subtilis; genotoxicity assessment; mutagenic activity; micronucleated cells; chromosomal aberrations N-acetylglucosamine; Bacillus subtilis; genotoxicity assessment; mutagenic activity; micronucleated cells; chromosomal aberrations

Share and Cite

MDPI and ACS Style

Zhang, L.; Hao, J.; Liu, X.; Yang, K.; Bai, L.; Hu, Q.; Feng, S. A Safety Evaluation of N-Acetylglucosamine Produced by Bacillus subtilis BNZR 2-7: A Comprehensive In Vitro and In Vivo Genotoxicity Assessment. Biomolecules 2025, 15, 1368. https://doi.org/10.3390/biom15101368

AMA Style

Zhang L, Hao J, Liu X, Yang K, Bai L, Hu Q, Feng S. A Safety Evaluation of N-Acetylglucosamine Produced by Bacillus subtilis BNZR 2-7: A Comprehensive In Vitro and In Vivo Genotoxicity Assessment. Biomolecules. 2025; 15(10):1368. https://doi.org/10.3390/biom15101368

Chicago/Turabian Style

Zhang, Liangliang, Jiahui Hao, Xuefang Liu, Kualian Yang, Lina Bai, Qingping Hu, and Saisai Feng. 2025. "A Safety Evaluation of N-Acetylglucosamine Produced by Bacillus subtilis BNZR 2-7: A Comprehensive In Vitro and In Vivo Genotoxicity Assessment" Biomolecules 15, no. 10: 1368. https://doi.org/10.3390/biom15101368

APA Style

Zhang, L., Hao, J., Liu, X., Yang, K., Bai, L., Hu, Q., & Feng, S. (2025). A Safety Evaluation of N-Acetylglucosamine Produced by Bacillus subtilis BNZR 2-7: A Comprehensive In Vitro and In Vivo Genotoxicity Assessment. Biomolecules, 15(10), 1368. https://doi.org/10.3390/biom15101368

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop